zh-twzhen
zh-twzhen

NEWS

合一生技股份有限公司 / 2022 / Oneness Biotech Co., Ltd. receives a European patent on the producing recombinant glycoproteins with modified glycosylation.

Oneness Biotech Co., Ltd. receives a European patent on the producing recombinant glycoproteins with modified glycosylation.

2022-01-20

Published Date:2022-01-20

Original Link:https://www.onenessbio.com/en/news_detail138_4.htm

No 1 Date of announcement 2022/01/20 Time of announcement 16:23:01
Subject Oneness Biotech Co., Ltd. receives a European patent on the producing recombinant glycoproteins with modified glycosylation.
To which item it meets paragraph 53 Date of events 2022/01/20
Statement
  1. Date of occurrence of the event:2022/01/20
  2. Company name:ONENESS BIOTECH CO., LTD.
  3. Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office
  4. Reciprocal shareholding ratios:NA
  5. Cause of occurrence:
    The Company has been informed by the patent agency that the methods for glycan modification on recombinant protein , has been granted a European patent entitled ”METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH MODIFIED GLYCOSYLATION”under the patent number EP 3119882 B1.
  6. Countermeasures:None
  7. Any other matters that need to be specified:None